UPL Ltd Research Report - 27th Jan 2017

Agrichemical | Published on Jan 27th 2017


UPL posted robust numbers for 3QFY2017. In sales, the company posted gross revenues of Rs3,987cr v/s Rs3,377cr in 3QFY2016, growth of 18% yoy. The growth was driven by volume (18% yoy), while price dip was around 3% and exchange gains added 3% to the top-line rise. On EBITDA front, the company posted an EBITDA of 17.8% v/s 14.7% in 3QFY2016. Along with this, dip of 15% and 2% in the deprecation & finance cost respectively aided the PBT to grow by 68% yoy. Consequently, PAT came in at Rs457cr v/s Rs300cr in 3QFY2016, growth of 52.4% yoy. The management has maintained guidance of 12-15% revenue growth (owing to presence in fast-growing countries) and 60-100bps improvement in EBITDA margin. We maintain our neutral rating on the stock.

Download Full Report


CMP 740
Target Price
Investment Period12 Months

Stock Info

MCAP BSE (Rs in Cr)Array
MCAP NSE (Rs in Cr)Array
P/E (x)Array
EPS (Rs.)Array
BV (Rs.)Array
Div Yield (%)Array
FV (Rs.)Array
P/BV (x)Array
EV/Sales (x)Array
EV/EBITDA (x)Array

Shareholding Pattern (%)

Public & Others-2.0
Grand Total100.0

Trade Securely


Portfolio Tracking & Trading Application View Demo